Health
An existing drug may function as targeted therapy for ALL in children – News-Medical.Net
A new study from Linköping University has shown that the tumour-inhibiting gene TET2 is silenced in a large fraction of cases…
A new study from Linköping University has shown that the tumor-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children. The scientists show that the gene can be reactivated by treatment with an existing…
Continue Reading
